Summary by Futu AI
HANGZHOU KAIMING MEDICAL DEVICES CO., LTD. (KAIMING MEDICAL-B) FILED ITS LATEST MONTHLY SECURITIES CHANGE REPORT WITH HONG KONG TRADING AND SETTLEMENT LIMITED ON MARCH 5, 2024, REPORTING THE STOCK CHANGES AS OF FEBRUARY 29, 2024. THE REPORT SHOWS THAT THE STATUTORY/REGISTERED CAPITAL OF THE COMPANY'S ORDINARY CLASS H SHARES (SHARE CODE 02500) LISTED ON THE HONG KONG EXCHANGE REMAINED UNCHANGED AT 441,010,235 SHARES WITH AN EQUIVALENT VALUE OF RMB 1 PER SHARE. In addition, the cash flow of non-listed foreign stocks remained at 1,208 shares. The Company's stock option plan was approved by the General Meeting on July 12, 2023. No change in share options during the month and the number of deposits is 0, but according to the plan, the company may issue a maximum of 44,101,023 new shares. The report does not mention changes in other categories of shares and confirms that all relevant legal documents have been formally filed and all conditions have been met.